NWTP is a collaborative of recognized engineering, business & government leaders helping conceptualize and cultivate strategic technologies and ventures at the intersection of business and public policy. We help plan and develop entrepreneurial businesses, promote them to the investment communities and launch “early adopter” marketing. Our focus is Critical Infrastructure and National Security. Since 1977 we have incubated game changing intellectual properties and launched new ventures for 3rd party clients and for our own portfolio.
CURRENT PORTFOLIO ENDEAVORS
- Probity Gradient™ methodology helps Executives & Public Officials manage CyberEnterprise risk by quantifying financial, reputation and geopolitical exposure – with emphasis on Critical Infrastructure and National Security.
- CyberQ™ CyberEnterprise Risk Analysis, co-developed with L3 Technologies, helps Bank Boards quantify Earnings and Capital exposure.
- AV Therapeutics develops treatments for cancers and Chem/Bio caused infectious diseases. CAPRIDINE™, which treats late stage prostate cancer, has achieved NCI recognized success in animals and is ready for FDA clinical trials.
- elive THERAPY treats heart failure by regenerating hibernating heart muscle cells. Outpatient treatment enables 1000s of cardiologists to save and extend millions of lives, preventing $Billions of hospital readmission and therapy expense.
To learn how NWTP can help you on-ramp your promising innovations and ventures, contact Info@NWTP.com or call (410) 507-1365